Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Creative Commons License

Soydal Ç., Demir B., Sütçü G., Araz M., Küçük N. Ö.

Molecular imaging and radionuclide therapy, cilt.32, sa.2, ss.150-152, 2023 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.4274/mirt.galenos.2023.47550
  • Dergi Adı: Molecular imaging and radionuclide therapy
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.150-152
  • Anahtar Kelimeler: Cancer, prostate, positron emission tomography, Ga-68-PSMA, F-18-PSMA
  • Ankara Üniversitesi Adresli: Evet

Özet

Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels,68Ga-prostate-specific membrane antigen (PSMA) or 18 F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in68Ga-PSMA positron emission tomography/computed tomography (PET/CT),18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.